Your browser doesn't support javascript.
loading
Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities.
Rieder, Marina; Gauchel, Nadine; Kaier, Klaus; Jakob, Carolin; Borgmann, Stefan; Classen, Annika Y; Schneider, Jochen; Eberwein, Lukas; Lablans, Martin; Rüthrich, Maria; Dolff, Sebastian; Wille, Kai; Haselberger, Martina; Heuzeroth, Hanno; Bode, Christoph; von Zur Mühlen, Constantin; Rieg, Siegbert; Duerschmied, Daniel.
Afiliación
  • Rieder M; Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Gauchel N; Department of Cardiology and Angiology I, Heart Center, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg, Germany.
  • Kaier K; Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. nadine.gauchel@universitaets-herzzentrum.de.
  • Jakob C; Department of Cardiology and Angiology I, Heart Center, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg, Germany. nadine.gauchel@universitaets-herzzentrum.de.
  • Borgmann S; Institute of Medical Biometry and Statistics, Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany.
  • Classen AY; Department I for Internal Medicine, Faculty of Medicine, University of Cologne, University Hospital Cologne, Cologne, Germany.
  • Schneider J; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
  • Eberwein L; Department of Infectious Diseases and Infection Control, Ingolstadt Hospital, Ingolstadt, Germany.
  • Lablans M; Department I for Internal Medicine, Faculty of Medicine, University of Cologne, University Hospital Cologne, Cologne, Germany.
  • Rüthrich M; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
  • Dolff S; School of Medicine, Technical University of Munich, University Hospital Rechts der Isar, Munich, Germany.
  • Wille K; 4Th Department of Internal Medicine, Klinikum Leverkusen, Leverkusen, Germany.
  • Haselberger M; Federated Information Systems, German Cancer Research Center, Heidelberg, Germany.
  • Heuzeroth H; University Medical Center Mannheim, Mannheim, Germany.
  • Bode C; Department for Internal Medicine II, Hematology and Medical Oncology, University Hospital Jena, Jena, Germany.
  • von Zur Mühlen C; Leibniz Institute for Natural Product Research and Infection Biology, Hans-Knöll Institute, Jena, Germany.
  • Rieg S; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Duisburg, Germany.
  • Duerschmied D; University Clinic for Haematology, Oncology, Haemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, University of Bochum, Bochum, Germany.
Clin Res Cardiol ; 111(3): 322-332, 2022 Mar.
Article en En | MEDLINE | ID: mdl-34546427
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tromboembolia / Trastornos de la Coagulación Sanguínea / SARS-CoV-2 / COVID-19 / Anticoagulantes Tipo de estudio: Observational_studies País/Región como asunto: Europa Idioma: En Revista: Clin Res Cardiol Asunto de la revista: CARDIOLOGIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tromboembolia / Trastornos de la Coagulación Sanguínea / SARS-CoV-2 / COVID-19 / Anticoagulantes Tipo de estudio: Observational_studies País/Región como asunto: Europa Idioma: En Revista: Clin Res Cardiol Asunto de la revista: CARDIOLOGIA Año: 2022 Tipo del documento: Article